Rituximab in childhood pemphigus vulgaris: A long-term follow-up case and review of the literature

Dermatology

Volumn 221, Issue 1, 2010, Pages 13-16

  Fuertes, Irene ^a   Guilabert, Antonio ^a   Mascaró Jr , Jose Manuel ^a   Iranzo, Pilar ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Pemphigus vulgaris, childhood; Rituximab

Indexed keywords

AZATHIOPRINE; CD20 ANTIGEN; COMPLEMENT COMPONENT C3; CYCLOSPORIN A; DAPSONE; DESMOGLEIN 1; DESMOGLEIN 3; GOLD; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ACANTHOLYSIS; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CASE REPORT; CELL COUNT; CELL MEMBRANE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CUSHING SYNDROME; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPITHELIUM CELL; EROSION; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; LIP DISEASE; LONG TERM CARE; LOW DRUG DOSE; MALE; MOUTH ULCER; ORAL BLISTER; PEMPHIGUS VULGARIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; STOMATITIS; TREATMENT RESPONSE; WOUND HEALING;

ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; AZATHIOPRINE; B-LYMPHOCYTES; CHILD, PRESCHOOL; DAPSONE; DESMOGLEIN 1; DESMOGLEIN 3; FEMALE; FOLLOW-UP STUDIES; GOLD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGUS; PREDNISONE; TREATMENT OUTCOME;

EID: 77955713077     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000287254     Document Type: Article

References (30)

1. Korman NJ: Pemphigus. J Am Acad Dermatol 1988; 18: 1219-1238.
2. Hamlet KR, Stevens SR, Gushurst C, Karabin G, Cooper KD: Juvenile pemphigus vulgaris associated with Graves' disease. J Am Acad Dermatol 1995; 33: 132-134.
3. Roca-Miralles M, Repiso T, Borona M, Kanitakis J, Vidal-Lliteras J, Castells-Rodellas A: Pemphigus vulgaire chez un enfant de 18 mois. Ann Dermatol Venereol 1993; 120: 777-779.
4. Kahn G, Lewis HM: True childhood pemphigus: pemphigus foliaceus in an 18-monthold child: immunofluorescence as a diagnostic aid. Am J Dis Child 1971; 121: 253-256.
5. Harangi F, Várszegi D, Schneider I, Zombai E: Complete recovery from juvenile pemphigus vulgaris. Pediatr Dermatol 2001; 18: 51-53.
6. Wananukul S, Pongprasit P: Childhood pemphigus. Int J Dermatol 1999; 38: 29-35.
7. Bjarnason B, Flosadóttir E: Childhood, neonatal, and stillborn pemphigus vulgaris. Int J Dermatol 1999; 38: 680-688.
8. Koturoglu G, Demir E, Kumbaraci BS, Kandiloglu G, Yurtsever SN: Pemphigus vulgaris in childhood: a case report. Minerva Pediatr 2008; 60: 347-349.
9. Paltzik RL, Laude TA: Childhood pemphigus treated with gold. Arch Dermatol 1978; 114: 768-769.
10. Yazganölu KD, Baykal C, Küçükölu R: Childhood pemphigus vulgaris: five cases in 16 years. J Dermatol 2006; 33: 846-849.
11. Szép Z, Danilla T, Buchvald D: Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins. Cas Lek Cesk 2005; 144: 700-703.
12. Bjarnason B, Skoglund C, Flosadóttir E: Childhood pemphigus vulgaris treated with dapsone: a case report. Pediatr Dermatol 1998; 15: 381-383.
13. Eming R, Nagel A, Wolff-Franke S, Podstawa E, Debus D, Hertl M: Rituximab exerts a dual effect in pemphigus vulgaris. J Invest Dermatol 2008; 128: 2850-2858.
14. Ahmed AR, Spigelman Z, Cavacini LA, Posner MR: Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med 2006; 355: 1772-1779.
15. Arin MJ, Engert A, Krieg T, Hunzelmann N: Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 2005; 153: 620-625.
16. Joly P, Mouquet H, Roujeau JC, D'Incan M, Gilbert D, Jacquot S, Gougeon ML, Bedane C, Muller R, Dreno B, Doutre MS, Delaporte E, Pauwels C, Franck N, Caux F, Picard C, Tancrede-Bohin E, Bernard P, Tron F, Hertl M, Musette P: A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 2007; 357: 545-552.
17. Schmidt E, Seitz CS, Benoit S, Bröcker EB, Goebeler M: Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 2007; 156: 352-356.
18. McDonald CJ: Cytotoxic agents for use in dermatology. Part I. J Am Acad Dermatol 1985; 12: 753-775.
19. Looney RJ, Anolik J, Sanz I: Treatment of SLE with anti-CD20 monoclonal antibody. Curr Dir Autoimmun 2005; 8: 193-205.
20. El Tal AK, Posner MR, Spigelman Z, Ahmed AR: Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2006; 55: 449-459.
21. Ramos-Casals M, Soto MJ, Cuadrado MJ, Khamashta MA: Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases. Lupus 2009; 18: 767-776.
22. Radhi M, Rumelhart S, Tatman D, Goldman F: Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab. J Pediatr Hematol Oncol 2007; 29: 125-127.
23. Quartier P, Brethon B, Philippet P, Landman- Parker J, Le Deist F, Fischer A: Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001; 358: 1511-1513.
24. Chira P, Sandborg CI: Novel therapies in pediatric rheumatic diseases. Curr Opin Pediatr 2003; 15: 579-585.
25. Nwobi O, Abitbol CL, Chandar J, Seeherunvong W, Zilleruelo G: Rituximab therapy for juvenile-onset systemic lupus erythematosus. Pediatr Nephrol 2008; 23: 413-419.
26. Kong HH, Prose NS, Ware RE, Hall RP 3rd: Successful treatment of refractory childhood pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol 2005; 22: 461-464.
27. Mamelak AJ, Eid MP, Cohen BA, Anhalt GJ: Rituximab therapy in severe juvenile pemphigus vulgaris. Cutis 2007; 80: 335-340.
28. Schmidt E, Herzog S, Bröcker EB, Zillikens D, Goebeler M: Long standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab. Br J Dermatol 2005; 153: 449-451.
29. Janisson-Dargaud D, Reguiaï Z, Perceau G, Eschard C, Bernard P: Juvenile pemphigus vulgaris. Ann Dermatol Venereol 2008; 135: 843-847.
30. Schmidt E, Goebeler M, Zillikens D: Rituximab in severe pemphigus. Ann NY Acad Sci 2009; 1173: 683-691.